‘Trans’ children given puberty blockers prior to medical consultation due to high demand
May 24, 2022 by Jill
from The Post Millennial:
The pre-pubescent girls who are injected with the drug designed to treat prostate cancer may, additionally, experience menopause after use.
A new directive from the Gender Pathways Service (GPS) at the Children’s Hospital in London, Ontario, instructs doctors that, due to high demand, puberty blockers may be prescribed to children prior to even being seen by a doctor.
The letter, shared by Billboard Chris, reads: “There is an extended wait time for an initial assessment through GPS. Given the distress that can be associated with Gender Dysphoria, we have also included information on puberty blockers that can be started prior to their initial appointment.”
In many nations, this kind of treatment has been put on hold pending further research, or banned altogether. In Canada and the US, the practice of putting healthy children on drugs to halt their natural development is full steam ahead.
Read here
